Diagnoptics

medical devices

About

Established in 2003, Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader™ - a state of art diagnostic device which can determine the tissue accumulation of AGEs in 30 seconds. Diagnoptics introduced the AGE Reader mu in 2013. This next generation AGE Reader has the same high measurement quality standard and combines this with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Technologies

Cloudflare DNS Gmail Google Apps YouTube Adobe Media Optimizer Cedexis Radar WordPress.org Vimeo Bootstrap Framework Mobile Friendly reCAPTCHA Google Analytics Nginx Google Tag Manager

Keywords

diabetes screening cardiovascular risk assessment medical technology noninvasive technologies medical equipment manufacturing glycation healthcare equipment & supplies clinical validation age-related diseases age interventions age accumulation measurement risk of diabetes medical device age in atherosclerosis clinical validation studies age measurement medical equipment and supplies manufacturing diagnostic device age reader app personalized care medical diagnostics skin tissue analysis patient monitoring services vascular health non-invasive risk assessment risk prediction skin autofluorescence technology preventive healthcare b2b

Location

4 Aarhusweg, Groningen, Groningen, Netherlands, 9723

Related Companies

Companies in the same industry